Support Alert

Drug Safety Update: Pseudoephedrine and ephedrine

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update highlighting that sales restrictions introduced in 2008 continue to be successful in managing the risk of misuse of pseudoephedrine and ephedrine. The update includes a 2017 review of the impact of restrictions.

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society